Literature DB >> 1922193

Polyene resistance in ergosterol producing strains of Candida albicans.

M C Broughton1, M Bard, N D Lees.   

Abstract

Following nitrous acid mutagenesis, one nystatin- (nyl) and two amphotericin B (AB)-resistant (ab1 and ab2) mutants of Candida albicans were isolated and characterized. The three mutants plus a previously described cytochrome P450-deficient mutant (D10) of this organism were analyzed for polyene cross resistance. Cross resistance was noted for ny1 and D10 but not for ab1 and ab2. Sterol analysis indicated that ny1 was a delta 8-delta 7 isomerase mutant while ab1 and ab2 showed wild type sterol profiles. Fatty acid analysis showed no significant differences for ab1, ab2, and ny1 compared to wild type while D10 showed more pronounced differences. AB- and Triton X-100-induced potassium leakage studies indicated that ab1 and ab2 are resistant to low AB levels and ny1 is resistant to higher AB levels. In contrast, ab1 and ab2 were more resistant to detergent-induced potassium leakage than the wild type or mutants ny1 and D10. Significant differences in growth rate, ethanol sensitivity, and response to Tergitol were also noted among the resistant strains. The data indicate a different mechanism of action for the two polyenes and indicate a resistance mechanism for ab1 and ab2 based on subtle alterations of membrane structure rather than sterol substitution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922193     DOI: 10.1111/j.1439-0507.1991.tb00623.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  10 in total

Review 1.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B.

Authors:  D W Denning; P Warn
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  Sterol and fatty acid composition of Candida lusitaniae clinical isolates.

Authors:  F Peyron; A Favel; R Calaf; A Michel-Nguyen; R Bonaly; J Coulon
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  A functional variomics tool for discovering drug-resistance genes and drug targets.

Authors:  Zhiwei Huang; Kaifu Chen; Jianhuai Zhang; Yongxiang Li; Hui Wang; Dandan Cui; Jiangwu Tang; Yong Liu; Xiaomin Shi; Wei Li; Dan Liu; Rui Chen; Richard S Sucgang; Xuewen Pan
Journal:  Cell Rep       Date:  2013-02-14       Impact factor: 9.423

5.  In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates.

Authors:  Sevtap Arikan; Luis Ostrosky-Zeichner; Mario Lozano-Chiu; Victor Paetznick; David Gordon; Tom Wallace; John H Rex
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.

Authors:  T L Wallace; V Paetznick; P A Cossum; G Lopez-Berestein; J H Rex; E Anaissie
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

7.  Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.

Authors:  E M Johnson; J O Ojwang; A Szekely; T L Wallace; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.

Authors:  Laura Y Young; Christina M Hull; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Antifungal application of nonantifungal drugs.

Authors:  Marios Stylianou; Evgeny Kulesskiy; José Pedro Lopes; Margareta Granlund; Krister Wennerberg; Constantin F Urban
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

Review 10.  Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections.

Authors:  Francelise B Cavassin; João Luiz Baú-Carneiro; Rogério R Vilas-Boas; Flávio Queiroz-Telles
Journal:  Infect Dis Ther       Date:  2021-02-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.